XOMA Corporation (XOMAO) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
XOMA Corporation (XOMAO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $538.7M, listed on NASDAQ, employing roughly 14 people, carrying a beta of 0.86 to the broader market. Based in Emeryville, California, and founded in 1981, XOMA Corporation functions as a specialized biotechnology royalty aggregator, with operations spanning Europe, the United States, and the Asia Pacific. Led by Owen Hughes Jr., public since 2021-04-12.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for XOMAO as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.